Literature DB >> 27049571

Systemic ocular antigen immunization leads only to a minor secondary immune response.

Sandra Kuehn1, Mathias Stellbogen1, Rozina Noristani1, Marcus Peters2, H Burkhard Dick1, Stephanie C Joachim3.   

Abstract

The immunization with optic nerve homogenate antigen (ONA) or S100 induced retinal degeneration. Since many neurological diseases are reinforced or initiated by immune cells, leucocytes were analyzed. CD3(+) T-cells in the retina increased slightly in ONA rats, but not in S100 treated retinas. No CD45R(+) B-cells and granulocytes could be detected in the retinas. At early stages, CD3(+) cells, Iba1(+) macrophages and granulocytes of the secondary lymphoid organs were not affected. Yet, the sole injection of pertussis toxin led to a shift to fewer CD45R(+) cells and more granulocytes in spleens. Later, splenic Iba1(+) macrophages were increased in both groups. We conclude that the retinal infiltration of lymphocytes is not crucial for the degeneration process and rather an epiphenomenon.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  FACS; Glaucoma; Granulocytes; Lymphocytes; Macrophages; Retina degeneration

Mesh:

Substances:

Year:  2016        PMID: 27049571     DOI: 10.1016/j.jneuroim.2016.02.017

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  4 in total

Review 1.  Modulation of the Immune System for the Treatment of Glaucoma.

Authors:  Katharina Bell; Nadine von Thun Und Hohenstein-Blaul; Julia Teister; Franz Grus
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

2.  T-Lymphocyte Subset Distribution and Activity in Patients With Glaucoma.

Authors:  Xiangjun Yang; Qun Zeng; Emre Göktas; Kalashree Gopal; Lama Al-Aswad; Dana M Blumberg; George A Cioffi; Jeffrey M Liebmann; Gülgün Tezel
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-03-01       Impact factor: 4.799

3.  Intravitreal Therapy Against the Complement Factor C5 Prevents Retinal Degeneration in an Experimental Autoimmune Glaucoma Model.

Authors:  Sabrina Reinehr; Sara C Gomes; Caroline J Gassel; M Ali Asaad; Gesa Stute; Marc Schargus; H Burkhard Dick; Stephanie C Joachim
Journal:  Front Pharmacol       Date:  2019-12-02       Impact factor: 5.810

Review 4.  Molecular regulation of neuroinflammation in glaucoma: Current knowledge and the ongoing search for new treatment targets.

Authors:  Gülgün Tezel
Journal:  Prog Retin Eye Res       Date:  2021-08-01       Impact factor: 21.198

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.